This HTML5 document contains 41 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n9http://linked.opendata.cz/ontology/domain/vavai/riv/statVydaniPatentuVzoru/
dctermshttp://purl.org/dc/terms/
n14http://localhost/temp/predkladatel/
n11http://linked.opendata.cz/resource/domain/vavai/riv/tvurce/
n20http://linked.opendata.cz/ontology/domain/vavai/riv/uzemniOchranaPatentu/
n4http://linked.opendata.cz/ontology/domain/vavai/
skoshttp://www.w3.org/2004/02/skos/core#
n12http://linked.opendata.cz/ontology/domain/vavai/riv/vyuzitiPatentuVzoru/
n3http://linked.opendata.cz/ontology/domain/vavai/riv/
n19http://linked.opendata.cz/ontology/domain/vavai/riv/licencniPoplatek/
n2http://linked.opendata.cz/resource/domain/vavai/vysledek/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n17http://linked.opendata.cz/ontology/domain/vavai/riv/vyuzitiJinymSubjektem/
n13http://linked.opendata.cz/ontology/domain/vavai/riv/klicoveSlovo/
n6http://linked.opendata.cz/resource/domain/vavai/vysledek/RIV%2F61989592%3A15110%2F10%3A10212249%21RIV11-MSM-15110___/
n21http://linked.opendata.cz/ontology/domain/vavai/riv/duvernostUdaju/
xsdhhttp://www.w3.org/2001/XMLSchema#
n15http://linked.opendata.cz/ontology/domain/vavai/riv/jazykVysledku/
n10http://linked.opendata.cz/ontology/domain/vavai/riv/aktivita/
n18http://linked.opendata.cz/ontology/domain/vavai/riv/druhVysledku/
n16http://linked.opendata.cz/ontology/domain/vavai/riv/obor/
n5http://reference.data.gov.uk/id/gregorian-year/

Statements

Subject Item
n2:RIV%2F61989592%3A15110%2F10%3A10212249%21RIV11-MSM-15110___
rdf:type
n4:Vysledek skos:Concept
dcterms:description
The invention relates to the uses of a triterpenoid compound or a pharmaceutically acceptable salt thereof, in therapy. The compound may be used for treating leukaemia, cancer or other proliferative disorder. The invention relates to the uses of a triterpenoid compound or a pharmaceutically acceptable salt thereof, in therapy. The compound may be used for treating leukaemia, cancer or other proliferative disorder.
dcterms:title
Triterpenoid derivatives Triterpenoid derivatives
skos:prefLabel
Triterpenoid derivatives Triterpenoid derivatives
skos:notation
RIV/61989592:15110/10:10212249!RIV11-MSM-15110___
n3:aktivita
n10:S
n3:aktivity
S
n3:cisloPatentuVzoru
US 7749988
n3:datumUdeleniPatentuVzoru
2010-07-06+02:00
n3:dodaniDat
n5:2011
n3:domaciTvurceVysledku
n11:7608543
n3:druhVysledku
n18:P
n3:duvernostUdaju
n21:S
n3:entitaPredkladatele
n6:predkladatel
n3:idSjednocenehoVysledku
293643
n3:idVysledku
RIV/61989592:15110/10:10212249
n3:jazykVysledku
n15:eng
n3:klicovaSlova
cancer treatment; Triterpenoid derivatives
n3:klicoveSlovo
n13:Triterpenoid%20derivatives n13:cancer%20treatment
n3:kontrolniKodProRIV
[E948998C8D8C]
n3:licencniPoplatek
n19:A
n3:mistoVydaniPatentuVzoru
Alexandria
n3:nazevVydavatelePatentuVzoru
United States Patent and Trademark Office; http://www.uspto.gov/
n3:obor
n16:CC
n3:pocetDomacichTvurcuVysledku
1
n3:pocetTvurcuVysledku
2
n3:rokUplatneniVysledku
n5:2010
n3:statVydaniPatentuVzoru
n9:US
n3:tvurceVysledku
Hajdúch, Marián Šarek, Jan
n3:uzemniOchranaPatentu
n20:B
n3:vlastnik
n6:vlastnikVysledku
n3:vyuzitiJinymSubjektem
n17:A
n3:vyuzitiPatentuVzoru
n12:A
n3:vlastnikPatentuVzoru
Univerzita Palackeho v Olomouci; Univerzita Karlova v Praze
n14:organizacniJednotka
15110